RC Capital announced on October 30 a new platform investment in The Blanchard Institute for an undisclosed price.
The Blanchard Institute is a North Carolina–based provider of intensive outpatient and partial hospitalization behavioral health services. The company offers a comprehensive continuum of mental health and substance use services.
Founded in 1994, RC Capital is a healthcare-focused growth equity firm based in Cincinnati, Ohio. The firm seeks to invest in commercial-stage medical technology companies operating in the healthcare services, medical devices and healthcare information technology sectors.
“The growth investment in The Blanchard Institute underscores RC Capital’s expertise and executive-led strategy in the behavioral health space and builds on our prior success with Mindpath Care Centers, another leading behavioral health company originally based in the mid-Atlantic,” said Vitaly Goldfeder, Principal at RC Capital.
According to data captured in the LevinPro HC database, this transaction marks the 90th Behavioral Health Care transaction to be announced since the start of 2025, and the 15th in the substance use disorder treatment specialty. There were 19 substance use disorder treatment acquisitions announced in 2024.
On the same day of this announcement, RC Capital also announced the successful exit of Oklahoma City-based FlexCare Infusion Centers, which operates 37 outpatient infusion centers across six states. Terms of that deal were not disclosed either.
